Fundamental dimension Equity attribute | AUTLLeader $1.54▼-2.53% Cap $409.9MP/E -1.5x QuantScore46/100 | ALLOPeer $1.250.00% Cap $431.9MP/E -1.9x QuantScore42/100 | ATRAPeer $8.59▼-8.91% Cap $86.22MP/E -7.3x QuantScore44/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
25/100 |
43/100 |
45/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 0/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 33/100 | 46/100 | 34/100 |
Growth Revenue / earnings growth & margins | 60/100 | 53/100 | 56/100 |
Sentiment Analyst ratings, targets & revisions | 77/100 | 69/100 | 51/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -1.5x | -1.9x | -7.3x |
Forward P/E (next FY) | -2.0x | -2.1x | -12.4x |
EV / EBITDA (TTM) | -1.5x | -3.0x | -6.8x |
Price / Sales | 3.5x | 93.1x | 13.9x |
Price / Free Cash Flow | -1.7x | -4.2x | -3.9x |
PEG ratio | 0.05 | -0.03 | 0.05 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 4 / 9 | 1 / 9 |
Altman Z-Score | -4.31 (Distress) | -3.36 (Distress) | -135.84 (Distress) |
Total debt / equity | 1.12 | 0.16 | -0.27 |
Quick ratio | 4.4x | 10.7x | 2.0x |
Interest coverage | -5.3x | -138.7x | -5.0x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +646.7% | -100.0% | -6.3% |
Net income growth YoY | -30.6% | +25.9% | +138.3% |
Gross margin (TTM) | 15.7% | 100.0% | 91.4% |
Operating margin (FY) | -372.4% | — | 29.7% |
FCF margin (FY) | -411.2% | — | -42.2% |
5. Trailing price performancePrice change over period |
1M return | -19.4% | -25.1% | +0.6% |
3M return | +6.2% | -28.2% | +8.7% |
6M return | +6.9% | -45.9% | +71.5% |
Year to date | -22.6% | -8.8% | -52.5% |
1Y return | +0.7% | +4.2% | -40.7% |
3Y return | -42.8% | -55.0% | -74.2% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-25.50 -1756.0% premium | $-0.1549 -112.4% premium | $-411.79 -4893.8% premium |
Wall Street consensus target | $8.87 +476.0% · range $7.60–$11.00 | $26.53 +2022.4% · range $3.85–$55.00 | $13.00 +51.3% · range $13.00–$13.00 |
Consensus stance | 79% Buy21% Hold0% Sell | 63% Buy33% Hold3% Sell | 31% Buy54% Hold15% Sell |